Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin.

Abstract

BACKGROUND Previously we reported that immunohistochemical examination of p53, bcl-2, glutathione S-transferase-pi (GST-pi), thymidylate synthase (TS) and vascular endothelial growth factor (VEGF) in biopsy samples was a useful method for predicting clinical outcome of gastric cancer patients treated with 5-fluorouracil and cisplatin. Here, we investigated… (More)

Topics

6 Figures and Tables

Cite this paper

@article{Nagashima2005BiologicalMA, title={Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin.}, author={Fumio Nagashima and Narikazu Boku and Atsushi Ohtsu and Shigeaki Yoshida and Takahiro Hasebe and Atsushi Ochiai and Yu Sakata and Hiroshi Saito and Yoshinori Miyata and Ichinosuke Hyodo and Masahiko Ando}, journal={Japanese journal of clinical oncology}, year={2005}, volume={35 12}, pages={714-9} }